Biohaven Stock Down Fund's Turnaround Bet Sparks Hope
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Read about user experiences with no fee travel points cards. Gain insights to enhance your travel rewards journey!
17,260 articlesA patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Baozun's baozun (bzun) 2025 earnings signal shifts in China’s DTC ecosystem. This article breaks down Q4 results, mar...
Even after a stellar quarter, Micron stock moved lower. This article reveals the secret reason micron stock traders a...
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Bernstein boosts its ServiceNow price target to $236 after the company's Analyst Day, underscoring margin upside even...
Investors eyeing DEI in 2026 should study the Q1 results, leverage, and lease metrics that shape the office REIT's tr...
Vice Capital Markets launches a public daily Par Note Rate benchmark, providing a market-based view of mortgage prici...
ETH failed to clear $2,400, hinting at a pullback toward the $2,000 zone. XRP lingers inside a pennant below $1.40, w...
A speculative bid by GameStop to purchase eBay sparks fresh debate about stock-based deals and the risk of overpaying...
In May, a calmer approach can shine. This article highlights two dividend stocks that are no-brainer buys for conserv...
Legislation momentum revives the XRP ETF narrative as institutions eye regulated XRP exposure via XRPFi on Flare, wit...
DRAM prices in Korea jumped nearly 500% year over year as Micron, Samsung, and SK Hynix tighten control, turning memo...